VTCN1 and type 1 diabetes mellitus: Its evaluation in mouse models of autoimmune diseases such as rheumatoid arthritis, type I diabetes, and contact hypersensitivity suggested that soluble B7-H4 might block the inhibitory functions of membrane B7-H4 and enhance T-cell-mediated autoimmune responses (240, 256, 257).